JB Chemicals, Cipla dragged to court for alleged infringement of Vifor FCM patent

Published On 2023-05-11 10:00 GMT   |   Update On 2023-05-11 10:00 GMT
Advertisement

Cipla Ltd and J B Chemicals and Pharmaceuticals have been embroiled in a court case as Swiss drug firm Vifor International moves Delhi High Court seeking permanent injunction restraining the two drug majors from alleged infringement of the patent of its iron carbohydrate complex drug ferric carboxymaltose (FCM).

Vifor International received the patent for manufacturing of water-soluble iron carbohydrate complex, designated as ferric carboxymaltose or iron carboxymaltose, which is used for the intravenous treatment of iron deficiency and iron deficiency anaemia when oral iron preparations are ineffective or cannot be used, on June 25, 2008 with a priority date of October 23, 2002 and the term of the patent expires on October 20, 2023.

Advertisement

For more details, check out the link given below:

Cipla, JB Chemicals Dragged To Court For Alleged Infringement Of Vifor FCM Patent



Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News